Cargando…

Autologous blood injection intracoronary artery for treating slow‐flow and no‐reflow in acute coronary syndrome related to primary pci

Slow‐flow and no‐reflow phenomenon are taken to sudden loss of coronary artery flow, typically after stenting or angioplasty in primary PCI. Otherwise conventional therapy, we report a technique, which autologous blood into intracoronary to supply oxygen and break process thrombosis results in succe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Truong Hoai, Lam, Nguyen Xuan, Duy, Nguyen Duc, Hung, Nguyen Tuan, Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864574/ https://www.ncbi.nlm.nih.gov/pubmed/35228873 http://dx.doi.org/10.1002/ccr3.5328

Ejemplares similares

No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction
por: Lim, Sang Yup
Publicado: (2016)

Optimising PCI by Intracoronary Image-guidance
por: Alasnag, Mirvat, et al.
Publicado: (2022)

Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)
por: Khan, Kamran Ahmed, et al.
Publicado: (2022)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2018)

Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study
por: Aksu, Tolga, et al.
Publicado: (2015)

Selective thrombolysis trans-catheter for safe and effective subacute stent graft occlusion treatment
por: Duc, Hung Nguyen, et al.
Publicado: (2023)

Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention
por: Gao, Ming-Dong, et al.
Publicado: (2020)

Efficacy and safety of intracoronary epinephrine for the management of the no-reflow phenomenon following percutaneous coronary interventions: a systematic-review study
por: Jafari Afshar, Elmira, et al.
Publicado: (2023)

Study on Correlation between Type 2 Diabetes and No-Reflow after PCI
por: Zhao, Su-Rui, et al.
Publicado: (2022)

Large intracoronary thrombus and its management during primary PCI
por: Kumar, Vinod, et al.
Publicado: (2020)

Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon
por: Qin, Tao, et al.
Publicado: (2013)

Clinical effect of preoperative high-dose atorvastatin against no-reflow after PCI
por: Liu, Wenbo, et al.
Publicado: (2017)

The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis
por: Savic, Lidija, et al.
Publicado: (2022)

Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention
por: Wang, Yong, et al.
Publicado: (2020)

Prevention of Migrating Atrial Septal Occluder in Large Hole Atrial Septal Defect Intervention by Snare
por: Truong Hoai, Lam, et al.
Publicado: (2023)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

Lipidomic Predictors of Coronary No-Reflow
por: Surendran, Arun, et al.
Publicado: (2023)

Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization
por: Kumar, Rajesh, et al.
Publicado: (2023)

Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study
por: Darwish, Ahmed, et al.
Publicado: (2022)

Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study
por: Singh, Rakendra, et al.
Publicado: (2022)

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD
por: Hosoda, Hayato, et al.
Publicado: (2023)

Successful Intracoronary Thrombolysis in Acute ST Elevation Myocardial Infarction Patient With Uncorrected Tetralogy of Fallot
por: Phan, Tan Quang, et al.
Publicado: (2021)

Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction
por: ZHAO, YU-JUN, et al.
Publicado: (2013)

Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis
por: Niu, Xiaowei, et al.
Publicado: (2018)

Primary intraperitoneal solitary fibrous tumor in mesentery: How does it present?()
por: Tuan, Ho Xuan, et al.
Publicado: (2022)

A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Zeng, Qian, et al.
Publicado: (2020)

Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe?
por: Robbers, L. F. H. J., et al.
Publicado: (2012)

Intracoronary Cavitation as a Cause of Plaque Rupture and Thrombosis Propagation in Patients with Acute Myocardial Infarction: A Computational Study
por: Rigatelli, Gianluca, et al.
Publicado: (2019)

The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI
por: Xiang, Yi, et al.
Publicado: (2019)

The predictive value of eosinophil levels on no-reflow in patients with STEMI following PCI: a retrospective cohort study
por: Mo, De-Gang, et al.
Publicado: (2022)

Intracoronary injection of nitroglycerine can prevent unnecessary percutaneous coronary intervention
por: Nasiri-Partovi, Amirhossein, et al.
Publicado: (2022)

Predictive Value of Soluble Growth Stimulator Gene 2 Protein for Coronary Slow Flow/No-Reflow in ST-Elevation Myocardial Infarction Patients Receiving Percutaneous Coronary Intervention
por: Chang, Shu-min, et al.
Publicado: (2022)

Low apparent diffusion coefficient in an extracranial brain tumor: a case report
por: Tuan, Ho Xuan, et al.
Publicado: (2022)

Slow depressurization following intradiscal injection leads to injectate leakage in a large animal model
por: Varden, Lara J., et al.
Publicado: (2019)

Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial
por: An, Su, et al.
Publicado: (2021)

Shock Index on Admission Is Associated with Coronary Slow/No Reflow in Patients with Acute Myocardial Infarction Undergoing Emergent Percutaneous Coronary Intervention
por: Wang, Qingcheng, et al.
Publicado: (2019)

A Massive Renal Infarction Due to Atheroemboli: A Case Report
por: Nguyen Tuan, Long, et al.
Publicado: (2023)

Vestibular schwannoma with fluid-fluid levels mimicking aneurysm bone cyst
por: Tuan, Ho Xuan, et al.
Publicado: (2023)

Autologous blood for preoperative colorectal TUMOR’S localization: A Vietnamese preliminary experience
por: Nguyen, Ngoc Hung, et al.
Publicado: (2022)

Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients
por: Li, Jing Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9khhn01b37pts62ne96fl154pu